CHAPTER 5 HPV infection and HPV-associated neoplasia in immunocompromised women (Q88336925)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29644644%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

title

CHAPTER 5 HPV infection and HPV-associated neoplasia in immunocompromised women (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29644644%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Joel Palefsky

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29644644%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

publication date

1 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29644644%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Gynecology and Obstetrics

23 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29644644%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

94 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29644644%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

S56-S64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29644644%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group.

23 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Incidence of cervical squamous intraepithelial lesions in HIV-infected women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Incidence of Cervical Squamous Intraepithelial Lesions Associated With HIV Serostatus, CD4 Cell Counts, and Human Papillomavirus Test Results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Prevalence and risk factors for anal squamous intraepithelial lesions in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Association of Cancer With AIDS-Related Immunosuppression in Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

The spectrum of HIV-1 related cancers in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

HIV and cervical cancer in Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Epidemiology of AIDS-related malignancies an international perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Immune deficiency and risk for malignancy among persons with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

HIV-Associated Anal Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Solid cancers after bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Cancer risk following organ transplantation: a nationwide cohort study in Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Anal cancer in renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Sexual health issues after lung transplantation: importance of cervical screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Abnormal cervical cytology in bone marrow transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

High rate of recurrence of cervical intraepithelial neoplasia after surgery in HIV-positive women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Anal cytology as a screening tool for anal squamous intraepithelial lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Treatment of grade III anal intraepithelial neoplasia with photodynamic therapy: report of a case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Photodynamic therapy for carcinoma in situ of the anus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

A controlled trial of a human papillomavirus type 16 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960011-3

10.1016/S0020-7292(07)60011-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29644644%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference